CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 8-K Event Delisting notice
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- S-3 Offering Registration Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Material agreement
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Medical Officer sold 5,584 shares at $0.58 ($3,243)
- 4 Open-market sale Chief Patient Supply Officer sold 5,584 shares at $0.58 ($3,243)
Page 3 of 41 · 808 filings